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Abstract
Background: Retinal detachment is a disorder of the eye in which sensory retina separates from the retinal
pigment epithelium (RPE) due to accumulation of fluid in subretinal space. Pharmacological stimulation of fluid
reabsorption from subretinal space to choroid across the RPE has been suggested as a treatment strategy for
retinal detachment. DPOFA, (R)-(+)-(5,6-dichloro 2,3,9,9a-tetrahydro 3-oxo-9a-propyl-1H-fluoren-7-yl)oxy]acetic acid, is
an abandoned drug capable of inhibiting Cl
-/HCO3
- exchanger activity. We hypothesized that DPOFA may increase
fluid absorption across basolateral surface of the RPE.
Methods: Reverse transcription polymerase chain reaction (RT-PCR) analysis of mRNA for six different transporters
that may act as Cl
-/HCO3
- exchangers was conducted in bovine and human RPE to confirm that RPE from two
species expresses the same repertoire of Cl
-/HCO3
- exchanger isoforms. The degree of amino acid homology
between orthologous human and bovine RPE-specific isoforms was calculated after performing protein alignments.
Transport of fluid across bovine RPE-choroid explants mounted in the Ussing chamber was used to assess the
ability of DPOFA to modulate fluid absorption across the RPE.
Results: Using RT-PCR we showed that three isoforms (SLC4A2, SLC4A3, and SLC26A6) are strongly expressed in
human and bovine RPE preparations. Amino acid comparisons conducted for RPE-specific isoforms support the use
of bovine RPE-choroid explants as an adequate experimental system for assessing fluid absorption activity for
DPOFA. Our data is consistent with the fact that DPOFA stimulates fluid absorption across the RPE in bovine RPE-
choroid explants.
Conclusions: DPOFA seems to stimulate transport of water across the RPE in bovine RPE-choroid explants.
Additional experiments are required to establish dose-dependent effect of DPOFA on fluid absorption in the
bovine RPE-choroid experimental system.
Background
Retinal detachment (RD) is the most common cause of
blindness in young adults [1-3]. In RD neuro-sensory
retina separates from the underlying pigment epithe-
lium due to accumulation of fluid in the subretinal
space [4]. The only therapy for RD is surgical re-
attachment. Surgery is most effective only if performed
within 1-3 days after the disease onset. The rate of
complications, often in a form of retinal re-detach-
ment, is 10-20%, even if successful surgical re-
attachment is performed in time [1]. Even when anato-
mical recovery in the form of retina reattachment is
successfully accomplished, functional recovery after
surgery may be poor due to the loss of photoreceptor
cells. Identification of the pharmacological treatment
for RD that can be used as adjunctive therapy to
improve functional outcomes following surgery and
reduce the rate of post-operative complications is of
upmost importance. Pharmacological up-regulation of
fluid reabsorption from subretinal space to choroid
across the retinal pigment epithelium (RPE) has been
suggested as potential treatment strategy for retinal
detachment [5]. In recent years, several drug candi-
dates have been tested in vivo and in vitro for the
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However, identification of clinically proven pharmaco-
logical therapy capable of increasing reabsorption of
subretinal fluid in retinal detachment patients remains
enigmatic. Removal of fluid from subretinal space
across the RPE is mainly driven by transport of K
+ and
Cl
- [12,13]. As basolateral Cl
-/HCO3
-exchanger
recycles Cl
- back to the RPE thus reducing the rate of
fluid absorption from subretinal space, the net move-
ment of water out of the RPE across basolateral sur-
face is determined by activity of the Cl
-/HCO3
-
antiporter [14]. Inhibition of the Cl
-/HCO3
-exchanger
would predictably lead to increase in water transport
across the RPE. DPOFA, (R)-(+)-(5,6-dichloro 2,3,9,9a-
tetrahydro 3-oxo-9a-propyl-1H-fluoren-7-yl)oxy]acetic
acid, is an abandoned fluorenone drug that has been
systemically administered to humans in clinical trials
for trauma-induced brain damage [15-17]. While the
primary molecular target for DPOFA is thought to be
aC l
-/HCO3
- exchanger [18-20], a Cl
- channel blocker
activity has also been suggested for this drug [21]. In
the present study we conducted preliminary analysis of
the effect of DPOFA on fluid transport using the
bovine choroid-RPE ex vivo system.
Methods
DPOFA synthesis
Chemical structure of DPOFA is shown in Figure 1.
DPOFA is not commercially available. A non-GMP
batch of DPOFA was synthesized by GVK Biosciences,
Hyderabad, India. HPLC purity of the synthesized com-
pound was confirmed and estimated to be 98%. Data
from the
1H NMR (400 MHz, CDCl3) and mass spectro-
metry analyses were in agreement with the compound
structure.
Preparation of solutions
DPOFA’s stock solution (40 mM) was prepared in 4.2%
NaHCO3, pH 6.3 as described previously [22,23]. The
medium used in fluid transport experiments was
HEPES-HCO3
-Ringer solution containing (in mM) 94.1
NaCl, 37 NaHCO3,3 . 8K C l ,1K H 2PO4,0 . 8M g S O 4,1 . 7
CaCl2, 6.9 glucose, and 20 HEPES. The pH was 7.4, and
the osmolarity was 290 mosmol/kgH2O. The solution
was pre-incubated at 37°C in 95%/5% air/CO2 for at
least 16 hours before experiments.
Preparation of RPE-choroid explants
Bovine eyes were obtained from Smithfield Beef Group,
Souderton, PA and kept in Ringer’s solution until their
use within 2.5-5 hours after enucleation. The eye was
dissected posteriorly to the ora serrata; lens and vitreous
were removed. Neurosensory retina was peeled away; a
circular area containing the RPE and choroid was cut
out using a cork bore. The RPE-choroid tissue prepara-
tion was placed on a metal mesh disk choroid (basal)
side down; nylon mesh was positioned on the RPE (api-
cal) side. The tissue explant was inserted between two
halves of the Ussing chamber which was pre-equili-
brated at 37°C.
Transport of fluid
The Ussing chamber was filled with pre-warmed Ring-
er’s solution, and electric resistance was tested to assure
tissue integrity. If electrical resistance was less than
100Ω, the preparation was discarded. Two cylinders
containing measuring capillaries were inserted into api-
cal and basal reservoirs of the Ussing chamber. Levels of
liquid in capillaries were adjusted using the specially
designed long barrel syringe. DPOFA was added to both
apical and basal reservoirs of the Ussing chamber. We
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Figure 1 Chemical structure of DPOFA. The compound is also known in the literature as B-3(+) [20] and L-644,711 [18].
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position reading in order to measure changes in the
position of a meniscus in the measuring capillaries in
response to fluid transport from apical to basal reser-
voir. The pumping rate was recorded as an increase in a
meniscus position of the basal capillary expressed in
micrometers. SigmaStat 3.0.1 package for Windows
from SPSS Inc. was used for data analysis.
RPE cell culturing, isolation of RNA, and RT-PCR
Primary fetal human RPE cell culture [24] was obtained
from Dr. Sheldon Miller, National Eye Institute. As sta-
ted in reference [24], the research on preparation of this
fetal human RPE culture followed the tenets of the
Declaration of Helsinki and was approved by the NIH
institutional review board. Primary fetal human RPE
cells were cultured according the published procedure
[24]. Bovine RPE was gently brushed off of the eyecup
after discarding the lens, vitreous, and neurosensory
retina. Total RNA was isolated from human RPE cells
and from bovine RPE tissue using the RNeasy kit (Qia-
gen) and a manufacturer’s protocol. After oligo(dT)-
primed cDNA synthesis, which was performed with the
ProtoScript First Strand cDNA Synthesis kit (New Eng-
land Biolabs), we confirmed expression of the estab-
lished RPE marker, bestrophin 1, using RT-PCR with
the following bestrophin 1 primers: 5’-GCAGAACA-
CAAGCAGTTGGA-3’ and 5’-TCTCCAAAGGGGTT-
GATGAG-3’ for human RPE; 5’-CAACCCATTTG
GAGAGGATG-3’ and 5’-AAGGTTCTTGGGC
TGGTTCT-3’ for bovine RPE. To assess expression of
anion transporter isoforms we conducted RT-PCR ana-
lysis using the following combinations of oligonucleotide
primers corresponding to different human and bovine
transporters: human SLC4A1, 5’-T C T T C C A G G A C -
CACCCACTA-3’ and 5’-CATGCCTACTACCAG-
CAGCA-3’;h u m a nS L C 4 A 2 ,5 ’-CCAGTGGATTCTC
GGTGACT-3’ and 5’-ATCCCGTTAAGGGAGGTGAC-
3’; human SLC4A3, 5’-CACCTACACGCAGAAGCTGA-
3’ and 5’- GGAAGATCCCAAAGAGCACA-3’;h u m a n
SLC26A3, 5’-CCATCATCGTGCTGATTGTC-3’ and 5’-
GCCTTGCTTCTGCAGTTTTC-3’; human SLC26A4,
5’- GGGCTGGATCTCGGTTTACT-3’ and 5’-CAAGG
CTATGGATTGGCACT-3’; human SLC26A6, 5’-
TTATCGGAGGCATCTTCCAG-3’ and 5’-C A G C A T
TGGCAAAGTACACG-3’; bovine SLC4A1, 5’-T C T T
CCAGGATCATCCACTGCA -3’ and 5’-GCCTATGAT-
CAGCAGCAGGT -3’;b o v i n eS L C 4 A 2 ,5 ’-C C A G T
GGCTTCTCAGTGACA -3’ and 5’- ATCCCATTCAG
GGAGGTCA -3’; bovine SLC4A3, 5’-CACCTACACA-
CAGAAGCTGACG -3’ and 5’- CAGGAAAATCC-
CAAAGAGCA -3’;b o v i n eS L C 2 6 A 3 ,5 ’- CTATCAT
TGTGCTGATTGTCGTT -3’ and 5’-GGCCTTTCTT
CTGCAGTTTTC -3’; bovine SLC26A4, 5’-GGGACTG
GACCTCGGTTTACT -3’ and 5’- GGCTATGGATT
GGCACTTTG -3’; bovine SLC26A6, 5’- GGGCAT
CTTCCAGTGCTTC -3’ and 5’- GGCGTTGGCGAAG-
TACAC -3’. Fragment sizes for all Cl
-/HCO3
- exchanger
PCR products were within the 493-509 b.p. range. Con-
trol GAPDH primers were 5’-GGTCTTACTCCTTG-
GAGGCCATGT-3’ and 5’- GACCCCTTCATTGACC
TCAACTACA-3’ for human cDNA (1 kb product size),
and 5’-ATGGTGAAGGTCGGAGTGAA-3’ and 5’-
ATGCCAAAGTGGTCATGGAT-3’ for bovine cDNA
(503 b.p. product size). Primer3 program combined with
BLAST search algorithm (Primer-BLAST available form
NCBI at http://www.ncbi.nlm.nih.gov/tools/primer-blast/
) was used to design all primers. Primer-BLAST allows
for specificity check of the selected primers against the
set of reference sequences. PCR was conducted accord-
ing to the previously described touch-down protocol
[25] with 26 cycles at annealing temperature of 55°C.
Amino acid comparisons
Protein alignments were performed at the EMBL-EBI
computer server using the ClustalW2 algorithm ( http://
www.ebi.ac.uk/Tools/msa/clustalw2/). Amino acid
sequence comparisons were conducted for the following
currently available SLC4A2, SLC4A3, and SLC26A6 pro-
tein sequences (GenBank accession numbers are shown
in parentheses): human SLC4A2 [GenBank:
NP_001186621], human SLC4A3 [GenBank:NP_005061],
human SLC26A6 [GenBank:NP_001035544], bovine
SLC4A2 [GenBank:NP_001192593], bovine SLC4A3
[GenBank:XP_615029], bovine SLC26A6 [GenBank:
NP_001070320], guinea pig SLC4A2 [GenBank:
NP_001166488], rabbit SLC4A2 [GenBank:
NP_001075788], and rabbit SLC4A3 [GenBank:
NP_001075499].
Results
It has been reported that DPOFA shows significant spe-
cies specificity in regard of inhibiting its main target,
Cl
-/HCO3
- exchanger. Human, cat, guinea pig, and rab-
bit constitute responsive species with similar high levels
of DPOFA inhibitory activities [18,19,26], while rodents
(rat and mouse) represent non-responsive species
[20,27]. Before conducting experiments on fluid absorp-
tion in bovine RPE-choroid system we wanted to con-
firm that isoform specificity of Cl
-/HCO3
- transporter in
bovine RPE is similar to that of the human RPE cells, to
assure that data obtained in bovine RPE system would
be predictive of outcomes in the human retina. It has
been reported that six different transporters from two
protein families may act as Cl
-/HCO3
- exchangers:
S L C 4 A 1 ,S L C 4 A 2 ,S L C 4 A 3 ,S L C 2 6 A 3 ,S L C 2 6 A 4 ,a n d
SLC26A6 [28,29]. We purified total RNA from cultured
primary fetal human RPE cells and from RPE tissue
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from human and bovine RNA, we confirmed expression
of the established RPE-specific marker, bestrophin 1,
using RT-PCR (data not shown). We synthesized oligo-
nucleotide primers from identical isogenic regions of six
human and bovine Cl
-/HCO3
- transporters and con-
ducted RT-PCR analysis in order to compare isoform
specificity of expressed anion transporters in human and
bovine RPE. As shown in Figure 2, the repertoire of Cl
-/
HCO3
- exchanger isoforms expressed in the RPE is
identical in human and Bos taurus with three isoforms
(SLC4A2, SLC4A3, and SLC26A6) pronouncedly
expressed in both RPE preparations. Control RT-PCR
reactions conducted with water in place of cDNA con-
firmed specificity of PCR amplification (Figure 2, panels
B, D). The degree of amino acid homology between
orthologous human and bovine Cl
-/HCO3
- isoforms
expressed in the RPE was calculated after performing
protein alignments using ClustalW2 algorithm. The
bovine-human homology for SLC4A2 and SLC4A3 iso-
f o r m si sa b o v e9 5 %w h i c hi si nt h er a n g eo fa m i n oa c i d
similarity between RPE-specific human transporters and
Cl
-/HCO3
-exchangers from three other “responsive” for
DPOFA species, cat, guinea pig, and rabbit (data not
shown). Lack of sequence information for the SLC26A6
transporter from cat, guinea pig, and rabbit precluded
us from performing similar analysis for this isoform.
Overall, amino acid comparisons conducted for SLC4A2
and SLC4A3 isoforms are consistent with the idea that
Bos taurus, along with human, cat, guinea pig and rabbit
m a yc o n s t i t u t ear e s p o n s i v ef o rD P O F As p e c i e sf u r t h e r
supporting the use of bovine RPE-choroid explants as
an adequate experimental system for assessing fluid
absorption activity for DPOFA. Attempting to define a
dose-dependent effect of the test compound on fluid
absorption, we conducted a series of experiments com-
paring DPOFA concentrations in the 1-20 μMr a n g e
with the effect of a compound vehicle over the period of
30 minutes. While no statistically significant difference
between compound doses could be established, we were
able to detect statistically significant increase in fluid
absorption after drug treatment versus vehicle control
during the first 20 minutes after drug or vehicle addition
when data for all DPOFA concentrations were com-
bined. When added in 1-20 μM concentrations, DPOFA
significantly (p = 0.013) increased water absorption
within first 20 minutes by 3.22 ± 1.4 μl/cm
2.hw h i l e
vehicle control decreased absorption by 2.1 ± 1.39 μl/
cm
2.h (Figure 3). Statistical significance could not be
reached when 10, 15, and 20 minute timepoints were
analyzed individually. The decrease in fluid absorption
by the RPE in response to vehicle addition is reminis-
cent of the previously reported volume flow decline
induced by “sham” treatment of choroid-RPE explants
mounted in Ussing-type chambers [30]. Table 1 shows
numeric data on changes in pumping rate over the per-
iod of 30 minutes in response to addition of 1-20 μM
DPOFA or vehicle with the number of experiments indi-
cated for each timepoint.
Discussion
Despite significant unmet medical need, there is no
pharmacological therapy that was approved by regula-
tory agencies for treatment of retinal detachment. Phar-
macological up-regulation of fluid reabsorption from
subretinal space to choroid across the retinal pigment
epithelium has been suggested as potential treatment
strategy for retinal detachment [5]. Basolateral Cl
-/
HCO3
- exchanger in the retinal pigment epithelium is a
reasonable drug target for up-regulation of fluid
Figure 2 Expression analysis of Cl
-/HCO3
- exchanger isoforms in human and bovine RPE. RT-PCR amplification was conducted on human
(A) and bovine (C) RPE cDNA preparations. Panels B and D show the results of control PCR amplification with human (B) and bovine (D)
isoform-specific primers performed with water in place of cDNA. Lanes 1-6 indicate PCR reactions performed with human (panels A, B) and
bovine (panels C, D) oligonucleotides specific for SLC4A1, SLC4A2, SLC4A3, SLC26A3, SLC26A4, SLC26A6, respectively. Lane 7 represents
amplification of the control GAPDH fragment performed with human (panels A, B) or bovine (panels C, D) oligonucleotide primers. Lane 8
contains size markers (100 b.p ladder) with arrow indicating a position of the 500 b.p. band.
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- back to the RPE thus
reducing the rate of fluid absorption from subretinal
space. DPOFA (shown in Figure 1), also known in the
literature as B-3(+) [20] and L-644,711 [18], is a non-
diuretic small molecule Cl
-/HCO3
- exchanger antagonist
that has been systemically administered to humans in
clinical trials for trauma-induced brain damage [15-17].
It has been shown that DPOFA exhibits remarkable spe-
cies specificity in regard of inhibiting its main target,
Cl
-/HCO3
- exchanger. While the IC50 of 2 × 10
-11 Mi n
the K
+-induced swelling assay is reported in one of the
responsive species, cats, the IC50 in a similar rat assay is
only 2 × 10
-7 M [16]. It has been shown that human,
cat, guinea pig, and rabbit constitute responsive species
with similar levels of DPOFA inhibitory activities
[18,19,26], while rodents (rat and mouse) represent non-
responsive species [20,27]. Bovine RPE-choroid system
is a widely used experimental tool for assessing the
effect of drug treatment on reabsorption of fluid across
the RPE [31-33]. However, in light of significant species-
specific difference in response to DPOFA in tissue slice-
based CNS experimental systems we wanted to develop
additional support for using bovine RPE-choroid system
as a tool capable of predicting DPOFA response in
human RPE. DPOFA’s selectivity for different Cl
-/
HCO3
- exchanger isoforms is not known. Assuming that
species-specific difference in response to DPOFA may
be caused by species-specific variations in repertoire of
expressed Cl
-/HCO3
- transporters, we compared iso-
form specificity of Cl
-/HCO3
- transporters expressed in
human and bovine RPE. Using RT-PCR analysis con-
ducted with isoform-specific oligonucleotide primers
that were designed from the isogenic regions of human
and bovine genes we showed that three isoforms
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Figure 3 Comparison of changes in water pumping rates in bovine RPE-choroid explants induced by DPOFA and vehicle treatment.
DPOFA at 1-20 μM concentrations was added to apical and basal baths of the chamber. The number of experiments and change in pumping
rate values are shown in Table 1. Mean values are plotted with error bars depicting Standard Error of Means (SEM). The change in pumping rate
from apical to basal side of the RPE-choroid explant was calculated at 10, 15, 20, and 30 minutes after drug and vehicle addition. While no
statistically significant difference between compound doses could be discerned, we were able to detect the statistically significant (p = 0.013)
increase in fluid absorption after drug treatment versus vehicle control during the first 20 minutes post drug/vehicle addition when the data for
all DPOFA concentrations within the 1-20 μM were pooled for the analysis.
Table 1 Change in pumping rate in response to DPOFA or vehicle treatment
Time after addition, min. DPOFA, Change in pumping rate
1 DPOFA, SEM
2 Vehicle, Change in pumping rate
1 Vehicle, SEM
2
10 3.64 (6) 3.49 -2.44 (5) 2.03
15 3.17 (4) 0.72 -1.71 (4) 3.08
20 2.83 (6) 1.22 -1.89 (4) 1.30
30 0.47 (10) 2.04 -0.44 (7) 0.68
1 Change in pumping rate in comparison with time 0 when DPOFA or vehicle were added is expressed in (μl/cm
2.h);
2SEM, Standard Error of Means; Number of
experiments is shown in parenthesis.
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Page 5 of 7(SLC4A2, SLC4A3, and SLC26A6) are strongly
expressed in both RPE preparations (Figure 2). After
defining transporters expressed in the RPE, we conducted
their amino acid comparisons in order to confirm that
human-bovine protein homology for RPE-specific trans-
porters is in line with the degree of similarity between
human and three other responsive species (cat, guinea
pig, and rabbit). These protein comparisons confirmed
that human-bovine homology for SLC4A2 and SLC4A3
does not differ from homology of RPE specific transpor-
ters in responsive for DPOFA species which may further
indicate that effect of the drug in bovine RPE-choroid
system is likely to adequately reflect the behavior of
DPOFA in human RPE. In an attempt to define a dose-
dependent effect of DPOFA on reabsorption of fluid in
the bovine RPE-choroid system, we conducted multiple
experiments assessing compound activity in the 1-20 μM
dose range on stimulation of water absorption across the
tissue explant (Table 1 and Figure 3). While no statisti-
cally significant difference between compound doses
c o u l db ed i s c e r n e d ,w ew e r ea b l et od e t e c ts t a t i s t i c a l l y
significant (p = 0.013) increase in fluid absorption after
drug treatment versus vehicle control during the first 20
minutes post drug/vehicle addition when data for all
DPOFA concentrations within the 1-20 μMr a n g ew e r e
pooled for the analysis. We speculate that our inability to
detect dose dependence in compound activity is consis-
tent with reported complexity of biological response to
DPOFA in another biological system. It has been shown
that titrations of DPOFA in a cerebrocortical slice swel-
ling assay produced the U-shaped dose response curve
with a maximum reduction of K
+-induced swelling in a
nanomolar range followed by decrease of drug activity at
higher micromolar concentrations [19,26]. Compound
evaluation outside of the micromolar range is essential
for establishing dose-dependent effect of DPOFA on fluid
absorption. Compound re-synthesis and additional stu-
dies are required in order to elucidate detailed pharmaco-
logical mechanisms of DPOFA activity in the RPE-
choroid explant system.
Conclusion
Preliminary analysis of DPOFA, a non-diuretic small
molecule Cl
-/HCO3
- exchanger antagonist, indicates that
this compound increases reabsorption of fluid across baso-
lateral surface of the retinal pigment epithelium in the ex
vivo bovine RPE-choroid system. Our results provide
rationale for additional experimental evaluation of this
compound as a potential treatment for retinal detachment.
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